RNF126
Basic information
Region (hg38): 19:647526-663233
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the RNF126 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 4 | |||||
missense | 44 | 45 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 44 | 4 | 1 |
Variants in RNF126
This is a list of pathogenic ClinVar variants found in the RNF126 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
19-648132-G-A | not specified | Uncertain significance (Jul 30, 2024) | ||
19-648145-C-T | not specified | Uncertain significance (May 28, 2024) | ||
19-648150-T-C | not specified | Uncertain significance (Jan 13, 2023) | ||
19-648171-G-A | not specified | Uncertain significance (May 10, 2024) | ||
19-648174-G-A | not specified | Uncertain significance (Jun 30, 2023) | ||
19-648201-A-T | not specified | Uncertain significance (Jul 12, 2022) | ||
19-648217-G-C | not specified | Uncertain significance (May 15, 2024) | ||
19-648262-C-T | not specified | Uncertain significance (Aug 28, 2023) | ||
19-648401-C-T | Benign (Jul 18, 2018) | |||
19-648410-G-T | not specified | Uncertain significance (Feb 15, 2023) | ||
19-648436-C-T | not specified | Uncertain significance (Nov 07, 2022) | ||
19-648437-G-A | not specified | Uncertain significance (Jul 09, 2024) | ||
19-648900-C-T | not specified | Uncertain significance (Aug 04, 2024) | ||
19-648945-G-A | not specified | Uncertain significance (May 18, 2023) | ||
19-648969-T-C | not specified | Uncertain significance (Nov 11, 2024) | ||
19-649738-G-A | not specified | Uncertain significance (Apr 19, 2024) | ||
19-650259-C-T | not specified | Uncertain significance (Dec 18, 2023) | ||
19-650280-C-T | not specified | Uncertain significance (Jan 19, 2024) | ||
19-651615-C-G | not specified | Uncertain significance (Jul 14, 2021) | ||
19-651627-C-T | not specified | Uncertain significance (Jul 02, 2024) | ||
19-651634-G-T | not specified | Uncertain significance (Dec 31, 2024) | ||
19-651650-C-T | not specified | Uncertain significance (Jun 30, 2024) | ||
19-651653-C-T | not specified | Uncertain significance (Jan 29, 2024) | ||
19-651665-C-T | not specified | Uncertain significance (Apr 15, 2024) | ||
19-651669-C-T | not specified | Uncertain significance (May 28, 2024) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
RNF126 | protein_coding | protein_coding | ENST00000292363 | 9 | 15752 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.954 | 0.0462 | 124133 | 0 | 2 | 124135 | 0.00000806 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.729 | 152 | 179 | 0.847 | 0.0000126 | 1955 |
Missense in Polyphen | 47 | 71.705 | 0.65546 | 749 | ||
Synonymous | -1.60 | 101 | 82.5 | 1.22 | 0.00000707 | 610 |
Loss of Function | 3.23 | 1 | 14.1 | 0.0711 | 6.83e-7 | 169 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00 | 0.00 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.0000182 | 0.0000180 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.00 | 0.00 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: E3 ubiquitin-protein ligase that mediates ubiquitination oF target proteins (PubMed:23277564, PubMed:24275455, PubMed:24981174). Depending on the associated E2 ligase, mediates 'Lys-48'- and 'Lys-63'-linked polyubiquitination of substrates (By similarity). Part of a BAG6-dependent quality control process ensuring that proteins of the secretory pathway that are mislocalized to the cytosol are degraded by the proteasome. Probably acts by providing the ubiquitin ligase activity associated with the BAG6 complex and be responsible for ubiquitination of the hydrophobic mislocalized proteins and their targeting to the proteasome (PubMed:24981174, PubMed:29042515). May also play a role in the endosomal recycling of IGF2R, the cation-independent mannose-6-phosphate receptor (PubMed:24275455). May play a role in the endosomal sorting and degradation of several membrane receptors including EGFR, FLT3, MET and CXCR4, by mediating their ubiquitination (PubMed:23418353). By ubiquitinating CDKN1A/p21 and targeting it for degradation, may also promote cell proliferation (PubMed:23026136). May monoubiquitinate AICDA (PubMed:23277564). {ECO:0000250|UniProtKB:Q91YL2, ECO:0000269|PubMed:23277564, ECO:0000269|PubMed:23418353, ECO:0000269|PubMed:24275455, ECO:0000269|PubMed:24981174, ECO:0000269|PubMed:29042515, ECO:0000305|PubMed:23026136}.;
- Pathway
- Immune System;Adaptive Immune System;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation
(Consensus)
Recessive Scores
- pRec
- 0.112
Intolerance Scores
- loftool
- 0.379
- rvis_EVS
- -0.47
- rvis_percentile_EVS
- 23.43
Haploinsufficiency Scores
- pHI
- 0.145
- hipred
- Y
- hipred_score
- 0.595
- ghis
- 0.537
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- S
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.768
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Rnf126
- Phenotype
Gene ontology
- Biological process
- ubiquitin-dependent protein catabolic process;protein monoubiquitination;protein ubiquitination;negative regulation of epidermal growth factor receptor signaling pathway;regulation of cell population proliferation;retrograde transport, endosome to Golgi;proteasome-mediated ubiquitin-dependent protein catabolic process;ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway;protein K63-linked ubiquitination;protein K48-linked ubiquitination;cytoplasm protein quality control by the ubiquitin-proteasome system
- Cellular component
- nucleus;nucleoplasm;cytoplasm;cytosol
- Molecular function
- epidermal growth factor receptor binding;protein binding;metal ion binding;ubiquitin protein ligase activity